Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. (2021)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2021.643310
PubMed Identifier: 33995362
Publication URI: http://europepmc.org/abstract/MED/33995362
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in immunology
ISSN: 1664-3224